EXANE DERIVATIVES - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$87,268,000
+6926.4%
2,279
+7496.7%
0.05%
Q1 2022$1,242,000
+9.6%
300.0%0.00%
Q4 2021$1,133,000
+14.6%
300.0%0.00%
Q3 2021$989,000
-99.6%
30
-99.3%
0.00%
-100.0%
Q2 2021$282,022,000
+12.0%
4,4470.0%0.06%
-11.1%
Q1 2021$251,778,000
-27.4%
4,447
+4.4%
0.07%
-29.4%
Q4 2020$346,883,000
+291.7%
4,258
+242.6%
0.10%
+292.3%
Q3 2020$88,559,000
-17.2%
1,243
-4.4%
0.03%
-10.3%
Q2 2020$106,957,000
+39.9%
1,3000.0%0.03%
+38.1%
Q1 2020$76,476,0001,3000.02%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders